copd update n.
Skip this Video
Loading SlideShow in 5 Seconds..
COPD Update 慢性阻塞性肺病 PowerPoint Presentation
Download Presentation
COPD Update 慢性阻塞性肺病

Loading in 2 Seconds...

play fullscreen
1 / 50

COPD Update 慢性阻塞性肺病 - PowerPoint PPT Presentation

  • Uploaded on

COPD Update 慢性阻塞性肺病 . Dr Arthur Chun-Wing Lau 刘俊颖 Intensive Care Unit, PYNEH Dec 2005. Definition of COPD (GOLD guidelines). A disease state characterized by airflow limitation that is not fully reversible

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
Download Presentation

PowerPoint Slideshow about 'COPD Update 慢性阻塞性肺病' - fiorella

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.

- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
copd update

COPD Update慢性阻塞性肺病

Dr Arthur Chun-Wing Lau 刘俊颖

Intensive Care Unit, PYNEH

Dec 2005

definition of copd gold guidelines
Definition of COPD (GOLD guidelines)
  • A disease state characterized by airflow limitation that is not fully reversible
  • The airflow limitation is usually both progressive and associated with an abnormal inflammatory response of the lungs to noxious particles and gases

Cigarette Smokers in Hong Kong

Thematic Household Survey 2003* (formerly called General Household Survey) by The Census and Statistics Department


Smoking accounts for most cases of COPD,

but only …..

15% of long-term heavy smokers will develop COPD

individual susceptibility
Individual susceptibility
  • Angiotensin-converting enzyme (ACE) gene
  • Transcription factors (myogenic basic helix-loop-helix gene D (MyoD) and myocyte-enhacer factor (MEF)-2
  • Proteins related to histone acetylation/deacetylation

Inflammatory cell interactions in COPD and the role of histone acetylation

1. Oxidants in cigarette smoke deactivates HDAC2, leading to histone acetylation, which in turn promotes unwinding of DNA

2. Cigarette also degradates IK-KB, releasing NF-KB

  • Oxidant-modified HDAC will not interact with glucocorticoid receptor
  • Low-dose theophylline markedly induces HDAC transcription
  • Imp: ? Combination of steroid and theophylline as treatment can break the cycle (ref: Cosio BG et al. J Exp Med 2004)

4. Transcription of IL-8, TNF-alpha and MMP is promoted

3. Unwinding of DNA allows NF-Kb greater access to DNA promoter elements

Ito K et al, NEJM 2005Shapiro SD, NEJM 2005

5. Leading to destruction of lung tissue

decreased histone deacetylase activity in chronic obstructive pulmonary disease
Decreased histone deacetylase activity in chronic obstructive pulmonary disease
  • HDAC is a key molecule in the repression of production of proinflammatory cytokines in alveolar macrophages.
  • Whether there is a link between the severity of disease and the reduction in histone deacetylase (HDAC) activity in the peripheral lung tissue of patients with COPD of varying severity.
  • Results:
    • Specimens of lung tissue obtained from patients with increasing clinical stages of COPD had graded reductions in HDAC activity and increases in interleukin-8 messenger RNA (mRNA) and histone-4 acetylation at the interleukin-8 promoter.
    • The mRNA expression of HDAC2, HDAC5, and HDAC8 and expression of the HDAC2 protein were also lower in patients with increasing severity of disease.
    • HDAC activity was decreased in patients with COPD, as compared with normal subjects, in both the macrophages and biopsy specimens
  • Conclusions:
    • Patients with COPD have a progressive reduction in total HDAC activity that reflects the severity of the disease.

Ito K et al, NEJM 2005

international copd genetics network
International COPD Genetics Network
  • Sponsored by GSK
  • Has enrolled 3500 patients
  • Aims:
    • to identify susceptibility genes for COPD to better define the manifestations of COPD
    • to help characterise intermediate phenotypes (with HRCT +/- inhaled hyperpolarised gas to produce 3-D images of the lung)




Fig. 1.— Sequential images of the right lung in a 71-yr-old male patient with emphysema obtained during deep, slow inspiration (a–d). e) Measurement of diaphragmatic excursion.

Ventral part of the diaphragm moved upward during inspiration. In this case, excursion was –3.6 cm and displacement was 2.6 cm. The paradoxical movement ratio (Mpr) during deep breathing was 42.3%.

Ref: Iwasawa T. Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema

Eur Respir J 2002; 19:225-231



Decrease of inspiratory capacity (due to dynamic hyperinflation) in 16 patients with COPD at rest and after metronome-paced hyperventilation (HV) and after exercise (EXE), when the resting respiratory rate was doubled, both before (left) and after (right) administration of 54 mcg inhaled IB

Increases in EELV and EILV from the resting respiratory rate to after exercise and after hyperventilation, both before (left) and after (right) administration of 54 {micro}g aerosolized IB

Gelb, A. F. et al. Chest 2004;126:1855-1860

rapid shallow breathing pattern
Rapid shallow breathing pattern
  • As an adaptive physiological responses which lessen the risk of respiratory muscle fatigue and minimise breathlessness
  • Leading to hypercapnia
  • Hypercapnia increases sense of dyspnoea

Gorini M, Misuri G, Corrado A, et al. Breathing pattern and carbon dioxide retention in severe chronic obstructive pulmonary disease. Thorax 1996;51:677–683.[Abstract]




Chronic bronchitis

the nature of small airways obstruction in copd
The nature of small-airways obstruction in COPD
  • Methods:
    • N=159, GOLD stages 0 to 4
    • The small airways were assessed in surgically resected lung tissue
  • Results:
    • The progression of COPD was strongly associated with an increase in the volume of tissue in the wall (P<0.001) and the accumulation of inflammatory mucous exudates in the lumen (P<0.001) of the small airways
    • percentage of the airways that contained polymorphonuclear neutrophils (P<0.001), macrophages (P<0.001), CD4 cells (P=0.02), CD8 cells (P=0.038), B cells (P<0.001), and lymphoid aggregates containing follicles (P=0.003) and the absolute volume of B cells (P=0.03) and CD8 cells (P=0.02) also increased as COPD progressed.

Hogg JC et al, NEJM 2004

  • COPD is an inflammatory disease
  • Inflammation persists even after cessation of smoking, reason for the persistence unknown
  • Increased numbers of activated T lymphocytes, ?may include memory T cells that may perpetuate the chronic inflammatory response
  • ? immunosuppressant therapies may be of value
mechanisms of airflow obstsruction
Mechanisms of airflow obstsruction
  • Emphysema: alveolar attachments may have reduced elasticity
  • Peripheral airway disease: the airway wall may be thickened by an inflammatory-cell infiltrate, by structural changes, by lymphoid follicles.
  • Chronic bronchitis: the airway lumen may be occluded by mucous secretions

Inhomogeneities of Ventilation and the Diffusing Capacity to Perfusion in Various Chronic Lung Diseases


A. Emphysema

B. Emphysema and chronic bronchitis

C. Peripheral airway disease

D. Peripheral airway disease and chronic bronchitis

VA/Q  and D/Q distributions in COPD (MIGET technique)

( A) Chronic pulmonary emphysema (CPE) only - bimodal V A/ Q distribution with high V A/Q regions. Therewere no low D/Q regions.

( B) Both CPE and chronic bronchitis (CB) components;inhomogeneity along the V A/ Q axis, but no low D/Q regions.

( C  Peripheral airway disease (PAD) only; bimodal V A/Q distribution in combinationwith low VA/Q. There were no regions with low D/ ratios.

(D) Both PAD and CB features; bimodal abnormalityin the V A/ Q distribution with low V A/Q areas. No low D/Q regions were found.

N = 25

YAMAGUCHI K et al. AJRCCM. Volume 156, Number 1, July 1997, 86-93

circulating inflammatory cytokines
Circulating inflammatory cytokines
  • TNF (DiFrancia et al AJRCCM 1994, 150: 1453 – 1455
  • IL-6 (Degigare et al, Chest, 2003, 124: 83 – 89)
  • Cause and effect to be established in skeletal muscle dysfunction
weight loss
Weight loss
  • Causes: Inc VO2 in resp and non-resp muscles, beta-2 agonists, theophylline, tissue hypoxia, inc activity of cytochrome oxidase (the mitochondrial enzyme that consumes oxygen)
  • Loss of skeletal muscle mass (main cause of weight loss), loss of fat mass (lesser extent) – Schols AMWJ et al, AJRCCM 1993)
  • An independent prognostic factor, in addition to FEV1 and PaO2
poor relationship between exercise and fev1
Poor relationship between exercise and FEV1
  • Correlation between normalised FEV1 and normalized peak VO2 is low, accounting for <25% of the variability (Bauerle et al. J Appl Physiol 1995)
reduced peak power output and vo2
Reduced peak power output and VO2
  • Contractile properties of the vastus lateralis are preserved (Debigare et al ERJ 2003, 21 273 – 278)
  • Strength/muscle X-section area was not different (Bernard et al AJRCCM 1998, 158: 629 – 634)
  • Small muscle mass peak VO2 same as in controls (Richardson et al, AJRCCM 2004, 169: 89 – 96)
early blood lactate accumulation
Early blood lactate accumulation
  • Of course (Maltais et al, JAP 1998, 84: 1573 – 1580)
  • But typical of deconditioning (and hypoxemia)
reduced muscle oxidative enzyme capacity
Reduced muscle oxidative enzyme capacity
  • Citrate synthase in the legs (Maltais et al, Thorax 2000, 55: 848 – 853)
  • But typical of deconditioning
  • Normal enzymes in deltoid muscles (GEA et al, ERJ, 2001, 17: 939 – 945)

Scheme of the major biochemical pathways for ATP production

Anaerobic glycolysis (Pathway B) occurs when there is inadequate O2 flow to mitochondria


Gas exchange during aerobic (A) and aerobic plus anaerobic (B) exercise

The acid-base consequence of (B) is a net increase in cell lactic acid production.

Buffering of lactic acid is predominantly by bicarbonate.

Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD
  • Methods: Nine COPD patients (age = 62 +/- 5 yr, mean +/- SD, FEV1 40 +/- 9% of predicted) and in nine normal subjects of similar age (54 +/- 3 yr). Following a transcutaneous biopsy of the vastus laterialis, each subject performed a stepwise exercise test on an ergocycle up to his or her maximal capacity
  • Aim to determination:
    • Glycolytic enzymes: lactate dehydrogenase, hexokinase, and phosphofructokinase
    • Oxidative enzymes: citrate synthase (CS) and 3-hydroxyacyl CoA dehydrogenase (HADH) levels (at vastus lateralis)
    • Serial lactate measurement during exercise

Maltais F et al AJRCCM 1996

  • No difference was found between the two groups for the glycolytic enzymes.
  • Activities of the oxidative enzymes was significantly lower in COPD than in control subjects for both citrase synthase (CS) and 3-hydroxyacyl CoA dehydrogenase (HADH)
  • Increase in lactic acid was steeper in COPD (b = 4.3 +/- 2.0 versus 2.1 +/- 0.2 for normal subjects, p = 0.0005).
  • Conclusion: In COPD the increase in arterial La during exercise is excessive, the oxidative capacity of the skeletal muscle is reduced, and that these two results are interrelated.
muslce histological differences type ii vs i fibers
Muslce histological differences: type II vs I fibers
  • Probably explains high VO2/power output
  • But may be due to long-term & extreme inactivity (Larsson et al, Muscle and Nerve, 1985, 8: 714 – 722)
  • Whittom, MSSE, 1998, 30: 1467 – 1474
  • Maltais ERJ 1999, 13, 850 – 854
  • Richardson et al, AJRCCM 2004, 169: 89 - 96
reduced anabolic hormones
Reduced anabolic hormones
  • Testosterone
  • IGF-1
  • Cause and effect in causing muscle dysfunction to be established

Kamischke et al, ERJ 1998, 11: 41-45

Debigare et al, Chest 2003, 124: 83 - 89

other potential systemic effects
Other potential systemic effects
  • Cardiovascular system
  • Nervous system effects
  • Osteoskeletal effects